PubMed Central (PMC3 - NLM DTD)
Archive of life sciences journal literature at the U.S. National Institutes of Health (NIH), developed and managed by NIH's National Center for Biotechnology Information (NCBI) in the National Library of Medicine (NLM).
The development of the ICD-11 Clinical Descriptions and Diagnostic Guidelines for
Mental and Behavioural Disorders - First, Michael B; Reed, Geoffrey M; Hyman, Steven E; Saxena, Shekhar
The World Health Organization is in the process of preparing the eleventh revision of the
International Classification of Diseases (ICD-11), scheduled for presentation to the World Health
Assembly for approval in 2017. The International Advisory Group for the Revision of the ICD-10
Mental and Behavioural Disorders made improvement in clinical utility an organizing priority for the
revision. The uneven nature of the diagnostic information included in the ICD-10 Clinical
Descriptions and Diagnostic Guidelines (CDDG), especially with respect to differential diagnosis, is
a major shortcoming in terms of its usefulness to clinicians. Consequently, ICD-11 Working Groups
were asked to collate diagnostic information about the disorders under their purview...
Prevalence of psychiatric disorders in U.S. older adults: findings from a nationally representative survey - Reynolds, Kristin; Pietrzak, Robert H; El-Gabalawy, Renée; Mackenzie, Corey S; Sareen, Jitender
Data on the prevalence of psychiatric disorders in late life are lacking. The present study addresses this gap in the literature by examining the prevalence of the broadest range of psychiatric disorders in late life to date; comparing prevalences across older adult age groups using the largest sample of adults aged 85+; and exploring gender differences in the prevalence of psychiatric disorders in late life. Using data from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions, we examined the prevalence of past-year mood, anxiety, and substance use disorders, and lifetime personality disorders in a nationally representative...
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial - Levkovitz, Yechiel; Isserles, Moshe; Padberg, Frank; Lisanby, Sarah H; Bystritsky, Alexander; Xia, Guohua; Tendler, Aron; Daskalakis, Zafiris J; Winston, Jaron L; Dannon, Pinhas; Hafez, Hisham M; Reti, Irving M; Morales, Oscar G; Schlaepfer, Thomas E; Hollander, Eric; Berman, Joshua A; Husain, Mustafa M; Sofer, Uzi; Stein, Ahava; Adler, Shmulik; Deutsch, Lisa; Deutsch, Frederic; Roth, Yiftach; George, Mark S; Zangen, Abraham
Major depressive disorder (MDD) is a prevalent and disabling condition, and many patients do not respond to available treatments. Deep transcranial magnetic stimulation (dTMS) is a new technology allowing non-surgical stimulation of relatively deep brain areas. This is the first double-blind randomized controlled multicenter study evaluating the efficacy and safety of dTMS in MDD. We recruited 212 MDD outpatients, aged 22–68 years, who had either failed one to four antidepressant trials or not tolerated at least two antidepressant treatments during the current episode. They were randomly assigned to monotherapy with active or sham dTMS. Twenty sessions of dTMS (18 Hz...